HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christoffer Clemmensen Selected Research

Dimethylphenylpiperazinium Iodide

1/2020Pharmacological targeting of α3β4 nicotinic receptors improves peripheral insulin sensitivity in mice with diet-induced obesity.
10/2018Coordinated targeting of cold and nicotinic receptors synergistically improves obesity and type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christoffer Clemmensen Research Topics

Disease

27Obesity
01/2021 - 05/2013
20Body Weight (Weight, Body)
01/2022 - 01/2014
12Type 2 Diabetes Mellitus (MODY)
01/2021 - 11/2013
8Weight Loss (Weight Reduction)
01/2022 - 04/2014
6Metabolic Diseases (Metabolic Disease)
01/2022 - 12/2015
6Insulin Resistance
01/2020 - 09/2012
3Dyslipidemias (Dyslipidemia)
01/2021 - 01/2017
3Glucose Intolerance
10/2018 - 10/2016
2Fatty Liver
01/2019 - 10/2016
1Seminoma
01/2022
1Testicular Neoplasms (Testicular Cancer)
01/2022
1Osteoporosis
01/2022
1Anorexia
01/2019
1Memory Disorders (Memory Loss)
01/2019
1Inflammation (Inflammations)
10/2017
1Hypertension (High Blood Pressure)
12/2016
1Tuberculosis (Tuberculoses)
12/2016
1Atherosclerosis
10/2016
1Hyperlipidemias (Hyperlipidemia)
10/2016
1Cardiovascular Diseases (Cardiovascular Disease)
10/2016
1Neoplasms (Cancer)
10/2016
1Diabetes Complications
01/2015
1Diabetes Mellitus
05/2014
1Weight Gain
01/2014
1Cachexia
01/2014
1Hyperphagia (Overeating)
09/2012
1Hypertrophy
04/2010

Drug/Important Bio-Agent (IBA)

11Glucagon-Like Peptide 1 (GLP 1)IBA
01/2021 - 11/2013
11Glucose (Dextrose)FDA LinkGeneric
01/2020 - 09/2012
5LeptinIBA
11/2018 - 04/2014
4Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2022 - 10/2018
4Glucagon (Glukagon)FDA Link
07/2019 - 04/2014
4Peptides (Polypeptides)IBA
01/2019 - 01/2015
3Insulin (Novolin)FDA Link
01/2021 - 01/2016
3Glucagon-Like Peptide-1 ReceptorIBA
01/2021 - 03/2015
3Pharmaceutical PreparationsIBA
07/2019 - 10/2016
3CholesterolIBA
10/2018 - 03/2015
3Hormones (Hormone)IBA
10/2016 - 12/2015
2Cholinergic Agents (Cholinergics)IBA
01/2022 - 06/2020
2Dimethylphenylpiperazinium IodideIBA
01/2020 - 10/2018
2celastrolIBA
03/2019 - 11/2018
2LiraglutideFDA Link
01/2019 - 03/2015
2GlucocorticoidsIBA
10/2017 - 07/2016
2Glucagon Receptors (Glucagon Receptor)IBA
10/2017 - 01/2015
2fibroblast growth factor 21IBA
10/2016 - 04/2014
1DenosumabFDA Link
01/2022
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
01/2022
1NicotineFDA Link
01/2022
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2021
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
06/2020
1Uncoupling Protein 1IBA
01/2020
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2020
1Glucagon-Like Peptides (Enteroglucagon)IBA
07/2019
1peptide PIBA
01/2019
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2019
1NeurotensinIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1MelanocortinsIBA
01/2019
1icilinIBA
10/2018
1Triglycerides (Triacylglycerol)IBA
10/2018
1Nonesterified Fatty Acids (NEFA)IBA
10/2018
1IncretinsIBA
10/2017
1Anti-Obesity Agents (Antiobesity Drugs)IBA
10/2017
1Thyroid HormonesIBA
10/2016
1Triiodothyronine (Liothyronine)FDA LinkGeneric
10/2016
1EnzymesIBA
10/2016
1Blood Glucose (Blood Sugar)IBA
01/2016
1SilverIBA
12/2015
1Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA
03/2015
1setmelanotideIBA
03/2015
1Peptide Receptors (Peptide Receptor)IBA
01/2015
1Bile Acids and Salts (Bile Acids)IBA
05/2014
1Dietary Fats (Dietary Fat)IBA
04/2014
1Exenatide (Byetta)FDA Link
04/2014
1relamorelinIBA
01/2014
1Anabolic AgentsIBA
01/2014
1GhrelinIBA
01/2014
1Ghrelin ReceptorsIBA
01/2014
1Biological ProductsIBA
05/2013
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2010

Therapy/Procedure

10Therapeutics
01/2021 - 04/2014
5Bariatric Surgery
01/2019 - 05/2014
4Drug Therapy (Chemotherapy)
07/2019 - 01/2017
2Glycemic Control
03/2015 - 01/2015
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2019
1Polypharmacy
12/2016
1Gastrectomy
05/2014
1Protein-Restricted Diet (Diet, Protein Restricted)
09/2012
1Resistance Training
04/2010